Yazar "Çubukcu, Erdem" için listeleme
-
Real-world treatment efficacy of ribociclib or palbociclib plus fulvestrant in hormone receptor-positive/HER2-negative metastatic breast cancer: Turkish oncology group (TOG) study
Kahraman, Seda; Erul, Enes; Gümüşay, Özge; Güven, Deniz Can; Aksoy, Sercan; Başaran, Gül; Seyyar, Mustafa; Şahin, Elif; Çabuk, Devrim; Bayram, Ertuğrul; Paydaş, Semra; Demirel, Burçin Çakan; Yaren, Arzu; Gülbağcı, Burcu; Hacıbekiroğlu, İlhan; Baytemur, Naziyet Köse; Demirci, Umut; Davarcı, Sena Ece; Demir, Hacer; Mocan, Eda Eylemer; Doğan, Özlem; Çılbır, Ebru; Yaşar, Alper; Bayoğlu, İbrahim Vedat; Hızal, Mutlu; Kayıkcıoğlu, Erkan; Çetin, Bülent; Acar, Ömer; Erdoğan, Atike Pınar; Keskinkılıç, Merve; Yavuzşen, Tuğba; Ünal, Olcun Ümit; Yılmaz, Funda; Doğan, Mutlu; Orhan, Sibel Oyucu; Çubukcu, Erdem; Erol, Cihan; Sakalar, Teoman; Dulgar, Özgecan; Karakaş, Yusuf; Özkanlı, Gülhan; Duman, Berna Bozkurt; Isık, Deniz; Karaoğlanoğlu, Müge; Okutur, Sadi Kerem; Yıldırım, Nilgün; Aydın, Esra; Uluç, Başak Oyan; Keser, Murat; Bilgin, Burak; Aksoy, Asude; Eren, Önder; Kalkan, Nurhan Önal; Er, Muhammed Muhiddin; Yücel, Hakan; Sunar, Veli; Paksoy, Nail; Aydın, Dinçer; Turhal, Nazım Serdar; Menekşe, Serkan (Elsevier, 2025)Background: Real-world (RW) data provide valuable information about the effectiveness and safety of treatment modalities in the general population that is not limited by selection criteria in clinical studies. The aim of ... -
Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey
Yerci, Ömer; Şehitoğlu, İbrahim; Uğraş, Nesrin; Çubukcu, Erdem; Yüce, Süleyman; Bedir, Recep; Cüre, Erkan (Asian Pacific Organization for Cancer Prevention, 2015)Background: Gastroenteropancreatic neuroendocrine tumors (GNs) are slow growing and although their incidence has increased in recent years, they are relatively rarely seen. Somatostatin analogues are used in the treatment ...
